PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer.

Lynce, Filipa; Saleh, Mervat; Shajahan-Haq, Ayesha; Gallagher, Christopher; Dilawari, Asma; Hahn, Olwen; Abu-Khalaf, Maysa; Cai, Ling; Pohlmann, Paula; Mohebtash, Mahsa; Kamugisha, Lois; Isaacs, Claudine

Lynce, Filipa; Saleh, Mervat; Shajahan-Haq, Ayesha; Gallagher, Christopher; Dilawari, Asma; Hahn, Olwen; Abu-Khalaf, Maysa; Cai, Ling; Pohlmann, Paula; Mohebtash, Mahsa; Kamugisha, Lois; Isaacs, Claudine.

Afiliação

Lynce F; MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, USA.
Saleh M; MedStar Washington Hospital Center, USA.
Shajahan-Haq A; Georgetown University, Lombardi Comprehensive Cancer Center, USA.
Gallagher C; MedStar Washington Hospital Center, USA.
Dilawari A; MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, USA.
Hahn O; University of Chicago, USA.
Abu-Khalaf M; Thomas Jefferson University, USA.
Cai L; Georgetown University, Lombardi Comprehensive Cancer Center, USA.
Pohlmann P; MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, USA.
Mohebtash M; MedStar Union Memorial Hospital, USA.
Kamugisha L; MedStar Good Samaritan Hospital, USA.
Isaacs C; Georgetown University, Lombardi Comprehensive Cancer Center, USA.